A L Edinger
Overview
Explore the profile of A L Edinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCracken A, McMonigle R, Tessier J, Fransson R, Perryman M, Chen B, et al.
Leukemia
. 2016 Aug;
31(3):669-677.
PMID: 27573555
The frequency of poor outcomes in relapsed leukemia patients underscores the need for novel therapeutic approaches. The Food and Drug Administration-approved immunosuppressant FTY720 limits leukemia progression by activating protein phosphatase...
2.
Guenther G, Liu G, Ramirez M, McMonigle R, Kim S, McCracken A, et al.
Oncogene
. 2013 Apr;
33(14):1776-87.
PMID: 23604129
Nutrient stress that produces quiescence and catabolism in normal cells is lethal to cancer cells, because oncogenic mutations constitutively drive anabolism. One driver of biosynthesis in cancer cells is the...
3.
Edinger A, Doms R
Methods Mol Med
. 2011 Mar;
17:41-9.
PMID: 21380656
Biological membrane fusion is an important part of many cellular processes and is a critical step in the entry of enveloped viruses, such as HIV-1, into cells. For HIV-1 to...
4.
Edinger A
Biochem Soc Trans
. 2005 Jan;
33(Pt 1):225-7.
PMID: 15667313
Growth factors provide permission signals that allow mammalian cells to grow, proliferate and survive. One mechanism by which growth factors maintain this control is through the regulation of cell surface...
5.
Plas D, Talapatra S, Edinger A, Rathmell J, Thompson C
J Biol Chem
. 2001 Mar;
276(15):12041-8.
PMID: 11278698
A comparison of Akt- and Bcl-x(L)-dependent cell survival was undertaken using interleukin-3-dependent FL5.12 cells. Expression of constitutively active Akt allows cells to survive for prolonged periods following growth factor withdrawal....
6.
Edinger A, Ahuja M, Sung T, Baxter K, Haggarty B, Doms R, et al.
J Virol
. 2000 Aug;
74(17):7922-35.
PMID: 10933700
In an attempt to generate broadly cross-reactive, neutralizing monoclonal antibodies (MAbs) to simian immunodeficiency virus (SIV), we compared two immunization protocols using different preparations of oligomeric SIV envelope (Env) glycoproteins....
7.
Edinger A, Clements J, Doms R
Virology
. 1999 Jul;
260(2):211-21.
PMID: 10417256
No abstract available.
8.
Edinger A, Blanpain C, Kunstman K, Wolinsky S, Parmentier M, Doms R
J Virol
. 1999 Apr;
73(5):4062-73.
PMID: 10196302
With rare exceptions, all simian immunodeficiency virus (SIV) strains can use CCR5 as a coreceptor along with CD4 for viral infection. In addition, many SIV strains are capable of using...
9.
Martin V, Ronde P, Unett D, Wong A, Hoffman T, Edinger A, et al.
J Biol Chem
. 1999 Mar;
274(13):8597-603.
PMID: 10085095
The mouse leukotriene B4 receptor (m-BLTR) gene was cloned. Membrane fractions of human embryonic kidney 293 cells stably expressing m-BLTR demonstrated a high affinity and specific binding for leukotriene B4...
10.
Edinger A, Hoffman T, Sharron M, Lee B, ODowd B, Doms R
Virology
. 1998 Oct;
249(2):367-78.
PMID: 9791028
Human and simian immunodeficiency viruses (HIV and SIV, respectively) use chemokine receptors as coreceptors along with CD4 to mediate viral entry. Several orphan receptors, including GPR1, GPR15, and STRL33, can...